Trial intelligence / Profile preview

DRINK: Probiotic Dairy Drink in Children

NCT00356382Phase 3Completed

Sponsor
Georgetown University
Start
Sep 2006
Primary completion
Jun 2007
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lactobacillus casei in respiratory tract infection (RTI), gastrointestinal infection and diarrhea, sponsored by Georgetown University. Primary endpoint: Mean of sick days due to upper-respiratory and gastro-intestinal infections and diarrhea. Started Sep 2006; status: completed.

02

Drugs

lactobacillus casei
03

Conditions

respiratory tract infection (RTI)gastrointestinal infectiondiarrhea

Beyond the preview

Go deeper on NCT00356382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00356382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call